Hepatic decompensation associated with lamivudine: A case report and review of lamivudine-induced hepatotoxicity

American Journal of Gastroenterology

Volumn 96, Issue 5, 2001, Pages 1619-1622

  Ormseth, Eric J ^a,b   Holtzmuller, Kent C ^a,b   Goodman, Zachary D ^c   Colonna, John O ^e   Batty, Donald S ^d   Sjogren, Maria H ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d Organ Transplant Serv Walter R   (United States)

^e Organ Transplant Serv Walter R ^*

Author keywords

[No Author keywords available]

Indexed keywords

EPIVER; HEPATITIS B ANTIBODY; LAMIVUDINE; NUCLEOSIDE ANALOG;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; COMORBIDITY; DRUG EFFECT; DRUG RESPONSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER INJURY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0035007915     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02369-3     Document Type: Article

References (15)

1. van Leeuwen R., Katlama C., Kitchen V., et al. Evaluation of safety and efficacy of 3-TC (lamivudine) in patients with asymptomatic or mildly symptomatic HIV infection A phase I/II study . J Infect Dis. 171:1995;1166.
2. Deinstag J.L., Perrilo R.P.P., Schiff E.R., et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 333:1995;1657-1661.
3. Schiano T.D., Lissoos T.W., Ahmed A., et al. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis. Am J Gastroenterol. 92:1997;1563-1564.
4. Karras A., Rabian C., Zylberberg H., et al. Severe anoxic hepatic necrosis in an HIV-1-hepatitic C virus-co-infected patient starting antiretroviral triple combination therapy. AIDS. 129:1998;827-829.
5. Lai C., Chein R., Leung N.W.Y., et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med. 339:1998;61-68.
6. Hart G.J., Orr D.C., Penn C.R., et al. Effects of 3TC,5′triphosphate on HIV transcriptase, and mammalian DNA polymerases, O,β, and γ Antimicrob Agents Chemother. 36:1992;1688.
7. Honkoop P., de Man R., Scholte H.R., et al. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B. Hepatology. 26:1997;211-215.
8. Bain V.G., Kneteman N.M., Mang M.M., et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication, and decompensated cirrhosis undergoing liver transplantation. Transplantation. 62:1996;1456-1462.
9. Van Thiel D.H., Friedlander L., Kania R.J., et al. Lamivudine treatment of advanced, and decompensated liver disease due to hepatitis B. Hepato-Gastroenterology. 44:1997;808-812.
10. Nery J.R., Weppler D., Rodriguez M., et al. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation. 65:1998;1615-1621.
11. Ben-Ari Z., Shmueli D., Mor E., et al. Beneficial effect of lamivudine pre-, and post-liver transplantation for hepatitis B infection. Transplant Proc. 29:1997;2687-2688.
12. Grellier L., Mutimer D., Ahmed M. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet. 348:1996;1212-1215.
13. Hoofnagle J.H., Hanson R.G., Minuk K.D., et al. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology. 95:1988;1318-1325.
14. Chisari F.V. Perspectives series. Host/pathogen interactions - Cytoxic T cells and viral hepatitis. J Clin Invest. 99:1997;1472-1477.
15. Boni C., Bertoletti A., Penna A. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest. 102:1998;968-975.